Vascular Endothelial Growth Factor plus Epidermal Growth Factor Receptor Dual Targeted Therapy in Metastatic Colorectal Cancer: Synergy or Antagonism?

por Marshall, John L.
Publicado 2009

Excitement for our future

por Marshall, John L.
Publicado 2021

Patients Living Longer With Metastatic Colorectal Cancer

por Marshall, John L., Sommers, Robin
Publicado 2016

Lessons Learned in Managing Patients with Colorectal Cancer During the COVID-19 Pandemic

por Mukherji, Reetu, Marshall, John L.
Publicado 2021

Genomic Alterations and Their Implications on Survival in Nonmetastatic Colorectal Cancer: Status Quo and Future Perspectives

por Mukherji, Reetu, Marshall, John L., Seeber, Andreas
Publicado 2020

Colorectal cancer care in the age of coronavirus: strategies to reduce risk and maintain benefit

por Marshall, John L, Yarden, Ronit I, Weinberg, Benjamin A
Publicado 2020

Stem Cells in Gastrointestinal Cancers

por He, Aiwu Ruth, Mendelson, Jonathan, Blake, Tiffany, Mishra, Lopa, Marshall, John L.
Publicado 2008

Recurrence of Early Stage Colon Cancer Predicted by Expression Pattern of Circulating microRNAs

por Shivapurkar, Narayan, Weiner, Louis M., Marshall, John L., Madhavan, Subha, Deslattes Mays, Anne, Juhl, Hartmut, Wellstein, Anton
Publicado 2014

Correction: Recurrence of Early Stage Colon Cancer Predicted by Expression Pattern of Circulating microRNAs

por Shivapurkar, Narayan, Weiner, Louis M., Marshall, John L., Madhavan, Subha, Deslattes Mays, Anne, Juhl, Hartmut, Wellstein, Anton
Publicado 2014

Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease

por Boyiadzis, Michael M., Kirkwood, John M., Marshall, John L., Pritchard, Colin C., Azad, Nilofer S., Gulley, James L.
Publicado 2018

Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States

por Kim, Sunnie, Signorovitch, James E., Yang, Hongbo, Patterson-Lomba, Oscar, Xiang, Cheryl Q., Ung, Brian, Parisi, Monika, Marshall, John L.
Publicado 2018

A Phase I Study of Ribociclib Plus Everolimus in Patients with Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy

por Weinberg, Benjamin A., Wang, Hongkun, Witkiewicz, Agnieszka K., Marshall, John L., He, Aiwu R., Vail, Paris, Knudsen, Erik S., Pishvaian, Michael J.
Publicado 2020

Molecular characteristics of hepatocellular carcinomas from different age groups

por Ang, Celina, Shields, Anthony, Xiu, Joanne, Gatalica, Zoran, Reddy, Sandeep, Salem, Mohamed E., Farhangfar, Carol, Hwang, Jimmy, Astsaturov, Igor, Marshall, John L.
Publicado 2017

Tissue and Serum microRNAs in the Kras(G12D) Transgenic Animal Model and in Patients with Pancreatic Cancer

por LaConti, Joseph J., Shivapurkar, Narayan, Preet, Anju, Deslattes Mays, Anne, Peran, Ivana, Kim, Sung Eun, Marshall, John L., Riegel, Anna T., Wellstein, Anton
Publicado 2011

Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma

por Gabrielson, Andrew, Tesfaye, Anteneh A., Marshall, John L., Pishvaian, Michael J., Smaglo, Brandon, Jha, Reena, Dorsch-Vogel, Karen, Wang, Hongkun, He, Aiwu Ruth
Publicado 2015

Quantification and expert evaluation of evidence for chemopredictive biomarkers to personalize cancer treatment

por Rao, Shruti, Beckman, Robert A., Riazi, Shahla, Yabar, Cinthya S., Boca, Simina M., Marshall, John L., Pishvaian, Michael J., Brody, Jonathan R., Madhavan, Subha
Publicado 2016

Results of an abbreviated phase-II study with the Akt Inhibitor MK-2206 in Patients with Advanced Biliary Cancer

por Ahn, Daniel H., Li, Junan, Wei, Lai, Doyle, Austin, Marshall, John L., Schaaf, Larry J., Phelps, Mitch A., Villalona-Calero, Miguel A., Bekaii-Saab, Tanios
Publicado 2015

The current state of molecular profiling in gastrointestinal malignancies

por Mukherji, Reetu, Yin, Chao, Hameed, Rumaisa, Alqahtani, Ali Z., Kulasekaran, Monika, He, Aiwu R., Weinberg, Benjamin A., Marshall, John L., Hartley, Marion L., Noel, Marcus S.
Publicado 2022

Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers

por Salem, Mohamed E., Weinberg, Benjamin A., Xiu, Joanne, El-Deiry, Wafik S., Hwang, Jimmy J., Gatalica, Zoran, Philip, Philip A., Shields, Anthony F., Lenz, Heinz-Josef, Marshall, John L.
Publicado 2017

A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma

por Tesfaye, Anteneh A., Wang, Hongkun, Hartley, Marion L., He, Aiwu Ruth, Weiner, Louis, Gabelia, Nina, Kapanadze, Lana, Shezad, Muhammad, Brody, Jonathan R., Marshall, John L., Pishvaian, Michael J.
Publicado 2019